| Rachel Korwek, SLP | |
|
382 S Main St, Cheshire, CT 06410-1379 | |
| (203) 250-9663 | |
| (203) 699-9641 |
| Full Name | Rachel Korwek |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 382 S Main St, Cheshire, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558149294 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7348 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Korwek, SLP 382 S Main St, Cheshire, CT 06410-1379 Ph: (203) 250-9663 | Rachel Korwek, SLP 382 S Main St, Cheshire, CT 06410-1379 Ph: (203) 250-9663 |
News Archive
Children with depression admitted to the hospital for other illnesses like pneumonia, appendicitis or seizure disorders, stay longer, pay more and are at greater risk of death, a Rutgers New Jersey Medical School study finds.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
Vanishing bile duct syndrome refers to a group of disorders characterized by destruction and disappearance of intrahepatic (inside the liver) bile ducts. Multiple causes have been identified including infections, malignancies, autoimmune conditions and adverse effects of medications. The usual course of this condition is variable and many patients with VBDS respond to treatment of the underlying condition and/ or removal of the offending agent. However, others progress to cirrhosis and end stage liver disease requiring liver transplantation.
The Joint West Africa Research Group began a study today designed to identify cases of suspected severe infectious disease at medical centers in West Africa. The study is being led by the U.S. Military HIV Research Program of the Walter Reed Army Institute of Research.
A clinical trial at Sanford Health is studying if an immunotherapy drug developed by Merck might be able to treat certain patients with advanced esophageal cancer. The Merck Keynote 181 trial is now open at Sanford.
› Verified 8 days ago
Colleen A Canas, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Mountain Rd, Cheshire, CT 06410 Phone: 203-213-1326 | |
Mrs. Megan Porto, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 | |
Mikayla Macclain, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Sara Barnick, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Mrs. Colleen Cull, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 132 Elm St, Cheshire, CT 06410 Phone: 203-250-9663 | |
Hannah Wilson, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Amanda Rodriguez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 |